두개내 동맥류 시장 : 유형, 적응증, 최종사용자별 - 세계 예측(2025-2030년)

The Intracranial Aneurysm Market was valued at USD 1.32 billion in 2023, expected to reach USD 1.60 billion in 2024, and is projected to grow at a CAGR of 22.16%, to USD 5.38 billion by 2030.

Intracranial aneurysms refer to the abnormal dilation of arteries within the brain, posing a significant health risk due to potential rupture, leading to severe complications like hemorrhagic stroke. The increasing incidence of lifestyle-related factors such as hypertension, smoking, and alcoholism drives the necessity for advanced diagnostic and therapeutic solutions. With innovations in neuroimaging technologies and minimally invasive surgical techniques, the intracranial aneurysm market is expanding. The primary applications are in the healthcare sector, particularly in neurodiagnostic centers and hospitals, focusing on endovascular coiling and flow-diverting stents. From an end-use perspective, healthcare providers, research institutions, and device manufacturers represent key stakeholders. Market growth is significantly influenced by technological advancements, increasing healthcare expenditures, and expanding access to healthcare services in emerging economies. Additionally, the aging global population, which experiences a higher prevalence of vascular disorders, presents further growth potential. However, challenges such as high costs of treatment, stringent regulatory approvals, and limited awareness in underdeveloped regions can impede market expansion. To capture emerging opportunities, companies should invest in R&D to develop cost-effective and efficient treatment modalities and partner with medical institutions for clinical trials and educational initiatives. The latest opportunities lie in the rise of AI-driven diagnostic tools and patient-specific treatment planning, which can enhance precision medicine. Nevertheless, economic constraints in low-income regions and high development costs remain significant hurdles. Innovative areas for research include the development of biodegradable stents, enhanced bioinformatics for early detection, and hybrid imaging techniques. The market is predominantly driven by technological advancements and strategic collaborations, thus necessitating a proactive approach in strategic partnerships and continuous innovation to cater to shifting market dynamics and patient needs.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Intracranial Aneurysm Market

The Intracranial Aneurysm Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising Prevalence of Cerebrovascular Disorder due to Changing Lifestyle
  • Inclination for Minimally Invasive Intracranial Aneurysm Procedures
  • Improved Diagnosis for Intracranial Aneurysm
• Market Restraints
  • Side Effects Associated with Therapies and High Cost of Treatments
• Market Opportunities
  • Rise in Research and Development Activities and Introduction of Innovative Technology Products
  • Rising Potential for Endovascular Coiling
• Market Challenges
  • Issues Related to Timing of Surgery and Anesthetic Induction

Porter's Five Forces: A Strategic Tool for Navigating the Intracranial Aneurysm Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Intracranial Aneurysm Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Intracranial Aneurysm Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Intracranial Aneurysm Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Intracranial Aneurysm Market

A detailed market share analysis in the Intracranial Aneurysm Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Intracranial Aneurysm Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Intracranial Aneurysm Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Intracranial Aneurysm Market, highlighting leading vendors and their innovative profiles. These include Adeor Medical AG, Oxford Endovascular Ltd., F. Hoffmann-La Roche AG, Mizuho Medical Co,Ltd., Penumbra, Inc., Acandis GmbH, Medtronic PLC, Abbott Laboratories, Integra Lifesciences Holdings Corporation, B. Braun Melsungen AG, Cardiatis, S.A., Johnson & Johnson Services, Inc., Bristol-Myers Squibb Company, Pfizer Inc., Microport Scientific Corporation, Evasc Medical Systems Corp, Balt Extrusion S.A., Terumo Corporation, Abbvie Inc., Bayer AG, Stryker Corporation, Merck & Co., Inc., and Kaneka Corporation.

Market Segmentation & Coverage

This research report categorizes the Intracranial Aneurysm Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Artery Occlusion & Bypass, Endovascular Coiling, Flow Diverters, and Surgical Clipping.
• Based on Indication, market is studied across Ruptured Aneurysm and Unruptured Aneurysm.
• Based on End User, market is studied across Clinics and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising Prevalence of Cerebrovascular Disorder due to Changing Lifestyle
    • 5.1.1.2. Inclination for Minimally Invasive Intracranial Aneurysm Procedures
    • 5.1.1.3. Improved Diagnosis for Intracranial Aneurysm
  • 5.1.2. Restraints
    • 5.1.2.1. Side Effects Associated with Therapies and High Cost of Treatments
  • 5.1.3. Opportunities
    • 5.1.3.1. Rise in Research and Development Activities and Introduction of Innovative Technology Products
    • 5.1.3.2. Rising Potential for Endovascular Coiling
  • 5.1.4. Challenges
    • 5.1.4.1. Issues Related to Timing of Surgery and Anesthetic Induction
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Demand for minimally invasive technique such as endovascular coiling for smaller, saccular aneurysms
  • 5.2.2. End User: Rising patient flow across clinics for early screening and diagnostic services
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization

6. Intracranial Aneurysm Market, by Type

• 6.1. Introduction
• 6.2. Artery Occlusion & Bypass
• 6.3. Endovascular Coiling
• 6.4. Flow Diverters
• 6.5. Surgical Clipping

7. Intracranial Aneurysm Market, by Indication

• 7.1. Introduction
• 7.2. Ruptured Aneurysm
• 7.3. Unruptured Aneurysm

8. Intracranial Aneurysm Market, by End User

• 8.1. Introduction
• 8.2. Clinics
• 8.3. Hospitals

9. Americas Intracranial Aneurysm Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Intracranial Aneurysm Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Intracranial Aneurysm Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Evasc announces clinical milestones and plans to expand European presence with German subsidiary
  • 12.3.2. OU Researchers Designing Device to Improve Brain Aneurysm Treatment

Companies Mentioned

• 1. Adeor Medical AG
• 2. Oxford Endovascular Ltd.
• 3. F. Hoffmann-La Roche AG
• 4. Mizuho Medical Co,Ltd.
• 5. Penumbra, Inc.
• 6. Acandis GmbH
• 7. Medtronic PLC
• 8. Abbott Laboratories
• 9. Integra Lifesciences Holdings Corporation
• 10. B. Braun Melsungen AG
• 11. Cardiatis, S.A.
• 12. Johnson & Johnson Services, Inc.
• 13. Bristol-Myers Squibb Company
• 14. Pfizer Inc.
• 15. Microport Scientific Corporation
• 16. Evasc Medical Systems Corp
• 17. Balt Extrusion S.A.
• 18. Terumo Corporation
• 19. Abbvie Inc.
• 20. Bayer AG
• 21. Stryker Corporation
• 22. Merck & Co., Inc.
• 23. Kaneka Corporation